|
|
||||||||
Departments of Physiology and Cardio-Thoracic Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania 19140
| |
ABSTRACT |
|---|
|
|
|---|
Defects in myocyte contraction and relaxation are
key features of human heart failure. Sodium/calcium exchanger-mediated
contribution to contraction and relaxation were separated from other
mechanisms [L-type calcium current, sarco(endo)plasmic reticulum
(SR)
Ca2+-ATPase]
based on voltage, temperature, and selective blockers. Rod-shaped left
ventricular myocytes were isolated from failed human explants
(n = 29) via perfusion with
collagenase-containing Krebs solution. Action potentials using
perforated patch and contractions using an edge detector were recorded
at 0.5-1.5 Hz in Tyrode solution at 25°C and 37°C.
Contraction duration was dependent on action potential (AP) duration at
37°C but not at 25°C, suggesting the role of the exchanger in
relaxation and linking myocyte relaxation to the repolarization phase
of the AP. Voltage-clamp experiments from
50 to +10 mV for 1,500 ms in Tyrode or Na+- and
K+-free solutions after
conditioning pulses triggered biphasic contractions that included a
rapid SR-mediated component and a slower voltage-dependent exchanger-mediated component. We used thapsigargin to
block the SR, which eliminated the rapid component, and we used an
exchanger blocker, Kanebo 7943, which eliminated the slow
component. The exchanger was shown to contribute to
contraction through reverse-mode exchange, as well as to play a key
role in relaxation of human ventricular myocytes.
human myocytes; heart failure; sodium/calcium exchange; excitation-contraction coupling
| |
INTRODUCTION |
|---|
|
|
|---|
ABNORMALITIES OF SYSTOLIC and diastolic function are key aspects in the pathophysiology of human heart failure. The impaired systolic function, evident as a decreased ejection fraction, has been directly related to contractile defects of individual myocytes. Myocyte contractile defects are thought to result primarily from changes in the calcium uptake and release mechanisms (11) and from the sensitivity of the myofibrils to calcium (29). Diastolic dysfunction includes a restrictive left ventricular filling pattern, increase in chamber stiffness, incomplete relaxation, and interstitial fibrosis (28). At the myocyte level, contraction is initiated by calcium influx with subsequent calcium release from the sarcoplasmic reticulum (SR) (22), and relaxation is a result of calcium removal from the cytoplasm by sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and the sarcolemmal sodium/calcium exchanger. Other mechanisms of calcium removal (sarcolemmal Ca2+-ATPase and mitochondrial uptake) are probably too slow to participate in the decay of the calcium transient (2, 3, 30).
In human heart failure, the expression of calcium regulatory proteins has been shown to be abnormal, with decreased levels of SERCA and increased levels of sodium/calcium exchanger protein (1, 12, 13, 18, 19, 23, 26). It has been suggested that a critical defect of myocyte function is the decreased capacity of the SR to accumulate calcium as a result of decreased SERCA activity (12). Recently, it has been (17) shown that in human heart failure the SR calcium load is decreased, resulting in lower steady-state and caffeine-induced calcium transients. Given that SR function is depressed and sodium/calcium exchange function is increased in heart failure, it is possible that calcium influx via reverse-mode sodium/calcium exchange and calcium efflux via forward-mode sodium/calcium exchange are more important processes in the contraction and relaxation of failed myocytes. Increased calcium influx via reverse-mode exchange activity during the action potential could be a source of intracellular calcium to help "replace" the SR as a mechanism for the activation of the myofibrils.
Prolongation of the action potential is a consistent finding in human heart failure (5, 6). The mechanism of action potential prolongation likely involves changes in potassium ion channel expression (6). It has been suggested that the increase in the duration of the action potential results in a greater influx of calcium through a prolongation of the plateau phase (5, 11). Contractions in the failing heart are longer and slower, suggesting that the prolonged action potential duration may be related to slower contraction and relaxation. If electrogenic sodium/calcium exchange makes a significant contribution to contraction and relaxation in failed human myocytes, then this might be the process that links the prolonged action potentials and contractions.
In this study, we examined the relationships between cellular contraction and relaxation to sodium/calcium exchange activity and the repolarization phase of the action potential. Our hypothesis was that the sodium/calcium exchanger made a significant contribution to contraction and relaxation in the failed human heart. Our objectives were to separate contraction and relaxation due to sodium/calcium exchange activity from other mechanisms of contraction (SERCA, L-type calcium current) and relaxation (SERCA, sarcolemmal Ca-ATPase, etc.) and to define the relationship between the myocyte action potential duration and relaxation. Furthermore, we sought to determine whether calcium influx via sodium/calcium exchange plays an important role in contraction of failed human myocytes.
| |
METHODS |
|---|
|
|
|---|
Cell isolation. We isolated left ventricular myocytes from 29 failed human explants. Etiologies included idiopathic dilated cardiomyopathy (11 hearts) and ischemic dilated cardiomyopathy (18 hearts). A blood vessel in a piece of left ventricular free wall (10 × 8 cm) was cannulated and perfused with calcium-free Krebs solution containing (in mM) 130 sodium chloride, 25 NaHCO3, 12.5 dextrose, 5.4 potassium chloride, 1 lactic acid, 1.2 MgSO4, 1.2 NaH2PO4, and 2 pyruvic acid for 30 min, followed by collagenase-containing Krebs solution (180 U/ml) for ~40 min at 37°C. The resulting rod-shaped myocytes had clear striations and did not demonstrate spontaneous contractions.
Electrophysiology.
All experiments were performed on single myocytes with no obvious
contact with neighboring cells. Suction-type patch pipettes were
prepared from borosilicate glass (1B150F, World Precision Instruments,
Sarasota, FL) using a two-stage pipette puller (model P-87, Sutter
Instruments, Novato, CA). The pipette tip was lightly heat polished
before use and had a tip resistance of 2 to 4 M
. The pipette was
attached to a patch-clamp amplifier (Axoclamp II, Axon Instruments,
Foster City, CA). A drop of cell suspension was placed in a Lucite
perfusion chamber (~20 × 10 × 10 mm) mounted on the
heated stage of an inverted microscope (Nikon Diaphot-TMD). The
experimental chamber was perfused with various bath solutions (see
above) at a rate of 1 to 2 ml/min. Before beginning a voltage-clamp experiment, we superfused cells with the bath solution for 3-5 min.
10-mV step were monitored to determine cellular
access (usually 5-10 min). The pipette solution contained (in mM)
120 potassium glutamate, 25 potassium chloride, 10 HEPES, 1 magnesium
chloride, 1 calcium chloride, and amphotericin B (240 µg/ml in DMSO),
pH 7.2 with potassium hydroxide. Amphotericin B caused
perforations in the cell membrane permitting electrical access to the
cell while preventing the dialysis of cellular components that could
alter ionic currents. For recording action potentials, continuous
current clamp mode was used. To initiate an action potential, a square
current pulse (0.25- to 0.5-ms duration) was applied at various
frequencies (0.2-2.0 Hz) in Tyrode solution containing (in mM) 150 sodium chloride, 10 dextrose, 5 HEPES, 2 sodium pyruvate, 5.4 potassium
chloride, 1.2 magnesium chloride, pH 7.4 with sodium hydroxide with 1 mM Ca2+. Contractions were
recorded simultaneously using a video edge detector (Crescent
Electronics, Salt Lake City, UT). The stimulus simultaneously activated
the recording of the action potential and the contraction via a PC for
storage and later measurement. The physiological pipette solution used
for whole cell voltage-clamp experiments was composed of (in mM) 110 potassium aspartate, 30 potassium chloride, 1 magnesium chloride, 5 HEPES, and 5 sodium ATP, pH 7.2 with potassium hydroxide. The sodium-
and potassium-free pipette solution contained (in mM) 140 cesium
chloride, 15 HEPES, 15 glucose, and 5 magnesium ATP, pH 7.2 with cesium
hydroxide. The sodium- and potassium-free bath solution contained (in
mM) 140 N-methyl-D-glucamine,
5.4 cesium chloride, 10 HEPES, 1 calcium chloride, and 1 magnesium
chloride, pH 7.4 with HCl. Whole cell currents and voltages were
measured using the discontinuous switch clamp, method (10). A sampling
rate of 10 kHz assured critical damping (maximum stability) of the
discontinuous voltage clamp, assuming an average cell capacitance of
300 pF and an average gain of 0.1 nA/mV. The data were sampled using a
12-bit analog-to-digital converter (Labmaster TL-1, Scientific
Solutions, Foster City, CA). Data acquisition and analysis were
controlled by pCLAMP 6.0 software (Axon Instruments) utilizing a
DOS-based PC. All experiments were carried out at 37°C except for
those experiments performed at 25°C where noted.
Drugs. The sodium/calcium exchange inhibitor Kanebo 7943 (KB-7943) was a kind gift from Kanebo (Osaka, Japan) (15) and was prepared as a 10 mM stock solution in DMSO and stored at 0°C until use. Thapsigargin (Sigma), a specific inhibitor of SERCA (16), was added to the bath solution, yielding a final concentration of 1 µM.
| |
RESULTS |
|---|
|
|
|---|
Action potential experiments.
Contractions induced by action potentials in failed human myocytes were
often biphasic with an initial rapid component followed by a second,
slower component (Fig.
1A).
Evidence of a biphasic contraction was apparent in 12 of 28 cells
studied at 37°C in response to an action potential at 0.5 Hz. The
rapid component began just after the upstroke of the action potential
and had a fast rate of shortening and relaxation
[
dL/dt,
12.79 ± 7.48 µm/s;
+dL/dt,
12.89 ± 7.79 µm/s, respectively;
n = 12, means ± SD],
suggesting that it was mediated by SR calcium release and uptake. The
second component had a significantly slower rate of shortening and
relaxation
[
dL/dt,
2.20 ± 1.10 µm/s; and
+dL/dt, 2.13 ± 1.09 µm/s, respectively;
n = 12, means ± SD],
suggesting that it was caused by a different process. At
stimulation frequencies of 0.2 to 1 Hz, the relaxation of the slower
component followed the repolarizing downstroke of the action potential,
whereas relaxation of the rapid component occurred during the plateau
of the action potential and did not change with rate-dependent
shortening of the action potential. At stimulation frequencies >0.5
Hz, the action potential duration shortened and only monophasic
contractions were observed. Under these conditions relaxation followed
the repolarizing downstroke of the action potential. These results suggested that the myocyte relaxation mechanism has voltage-dependent and -independent components and suggests that removal of intracellular calcium by forward-mode sodium/calcium exchange together with calcium
uptake by the SR are the processes involved in relaxation.
|
Effect of temperature.
Previous studies have shown that the sodium/calcium exchanger has a
higher temperature sensitivity than SERCA in guinea pig myocytes (27).
Therefore, contractions at 25°C should rely less on the
sodium/calcium exchanger. The duration of the contraction was longer at
25°C than at 37°C (Table
1), and the relaxation phase occurred
well after the repolarization of the action potential (Fig.
1B). Under these conditions,
relaxation had no obvious voltage dependence, supporting the idea that
electrogenic sodium/calcium exchange played less of a role in
relaxation with the SR functioning as the principal mechanism of
relaxation at 25°C. Action potential and contraction data from 18 myocytes (10 hearts) recorded at 37°C (0.2, 0.5, and 1 Hz) were
compared with data from six myocytes (4 hearts) recorded at 25°C.
The index derived by dividing the duration of the contraction by the
duration of the action potential was significantly greater at 25 vs.
37°C, indicating that relaxation was influenced to a lesser extent
by the repolarization of the action potential. (Fig.
1C).
|
Voltage-clamp experiments.
To further explore the basis of the two components of contraction,
failed myocytes were studied using voltage-clamp techniques. From a
holding potential of
50 mV, after six conditioning pulses to +10
mV (to load the SR), a 1,500-ms step was made to +10 mV to maximally
activate L-type calcium current and trigger contraction. We repeated
this protocol and shortened the duration of the test pulse (after
conditioning pulses) with each subsequent step by 150 ms.
In Tyrode solution with physiological filling solution at 37°C, the
long initial contraction (1,500-ms pulse) was usually biphasic with a
rapid and a slow component. The relaxation rate of the fast component
did not change with repolarization until pulse duration was less than
500 ms. Relaxation of the slower component always followed the
repolarization at the end of the test pulse (Fig.
2A).
These results showed that relaxation of the second component was
voltage dependent and was consistent with a sodium/calcium exchange
mechanism.
|
Effect of thapsigargin.
To further explore the basis of the two components of contraction,
action potentials and contractions were recorded at 37 °C before
(Fig.
3A) and
after exposure to 1 µM thapsigargin (Fig. 3B). Thapsigargin specifically
inhibits SERCA (16), leaving the L-type calcium current and
reverse-mode sodium/calcium exchange as the principal sources of
calcium influx to activate the myofilaments and forward-mode
sodium/calcium exchange as the primary route of calcium
removal. Action potential characteristics after exposure to thapsigargin did not change significantly (Fig.
3B). Thapsigargin eliminated the
first component of contraction. The remaining thapsigargin-insensitive contraction was very slow to reach peak, consistent with direct activation of the myofilaments from calcium influx during the action
potential (Fig. 3B). The relaxation
of this slower contraction depended on the repolarization of the action
potential as before. In voltage-clamp experiments, thapsigargin
abolished the rapid but not the slower component of contraction,
consistent with elimination of SR calcium release. Different methods
were used to "condition" the cell and to establish steady-state
contractions in the absence of SR function. Action potentials at 0.5 Hz, voltage steps to +10 mV (maximal L-type calcium current, Fig.
3C) and to +50 mV (physiological
overshoot, L-type calcium current and exchanger current, Fig.
3D), and to +135 mV (exchanger
current only, data not shown) were used to initiate contractions and
condition the cell. Slow contractions were initiated, and
in all cases the relaxation was closely linked to the repolarization at
the end of the voltage step (Fig. 3, C
and D,
bottom). These results provide
further proof that the relaxation of the first component of contraction was SR mediated, and the relaxation of the second component was voltage
dependent and therefore exchanger mediated under these conditions.
Contractions initiated by voltage steps to +10 mV (predominantly L-type
calcium current), to +50 mV (L-type calcium current and exchanger
current), and to +135 mV (exchanger current only) resembled the slow
component of the action potential-triggered contraction and suggested
an important role for reverse-mode calcium entry in the initiation of
contraction. These results showed that in the absence of a functional
SR, the sodium/calcium exchanger played a significant role both in
contraction and relaxation of the myocyte. Similar results were seen in
eight myocytes (four hearts).
|
Effect of KB-7943.
Myocytes at 37°C were exposed to 10 µM KB-7943, a specific
blocker of sodium/calcium exchange (15). The duration of the action
potential was significantly decreased after exposure to 10 µM KB-7943
(Fig. 4A,
mean action potential duration at 90% repolarization at 0.5 Hz:
37°C, 1,100 ± 360 ms control vs. 533 ± 144 ms
KB-7943, P < 0.05, n = 3), suggesting that the
sodium/calcium exchange current was an important contributor to the
action potential plateau. The accompanying contractions were monophasic
with relaxation not clearly linked to the repolarization of the action
potential. These results show that when contraction and relaxation are
strictly SR-mediated (exchanger blocked), the rate of relaxation is
independent of voltage. In voltage-clamp experiments, the current
records of myocytes exposed to 10 µM KB-7943 had no obvious exchanger current (Fig. 4B), and contractions
were monophasic (no exchanger component) and not linked to the
repolarization after the voltage step (Fig.
4C). These results showed that in
the absence of the exchanger, relaxation does not depend on voltage.
Similar results were seen in four myocytes (three hearts).
|
Reverse-mode exchange.
To understand the contribution of reverse-mode exchange to contraction,
we used a protocol that stepped (without conditioning pulses) from
50 mV to +50 mV, the approximate plateau potential, where L-type
calcium current is small and reverse-mode exchange current should be
large. These experiments were carried out after a 60-s
rest period. The net current was outward during the entire pulse,
suggesting reverse-mode exchange occurred continuously during repeat
loading steps (Fig.
5A,
top). Repeat steps (without conditioning pulses) from
50 mV to +50 mV initiated contractions with increasingly larger first components (Fig.
5A,
bottom) with each successive pulse,
suggesting that reverse-mode exchange loaded the SR. Similar to
experiments using conditioning pulses, complete relaxation relied on
the repolarization at the end of the test pulse. When
conditioning pulses were included in the protocol (Fig.
5B), the rapid component of
contraction (SR mediated) was followed by a slower exchanger-mediated
contraction that did not relax until repolarization at the end of the
test pulse. When the test steps were preceded by conditioning pulses
(Fig. 5B), the net current during
the pulse was initially outward followed by net inward current for the
remainder of the pulse, suggesting that the loading protocol maintained
higher levels of intracellular calcium.
|
50 mV to
+10, +50, and +80 mV after 60 s rest, without conditioning pulses, were
applied to determine the relative contribution of L-type calcium
current and sodium/calcium exchange to the initiation of contraction
(and indirectly to SR calcium loading). Repeat steps to +10 mV
activated large L-type calcium current with small contractions and
little evidence of a staircase effect (Fig.
5C, left). Steps to +50 mV activated a
small amount of L-type calcium current, a large inward sodium/calcium
exchange current, and larger contractions with a significant staircase
effect (Fig. 5C,
middle). Steps to +80 mV activated a
large outward current with little evidence of L-type calcium current
(as expected) and initiated large contractions (Fig.
5C,
right). At the end of the test pulse the step back to
50 mV activated "tail" L-type calcium
currents with small contractions. These results suggest that
reverse-mode sodium/calcium exchange plays an important role in the
calcium loading of the SR and participation in the initiation of
contraction in failed human myocytes. Similar results were seen in six
myocytes (four hearts).
| |
DISCUSSION |
|---|
|
|
|---|
These results demonstrate for the first time the important role of the sodium/calcium exchanger in contraction and relaxation of failed human ventricular myocytes. Contractions had two distinct components in response to an action potential or a voltage-clamp pulse and suggested that contraction of human myocytes is mediated through two mechanisms: a rapid SR-mediated phase and a slower exchanger-mediated phase. Depending on the apparent degree of SR dysfunction, contractions varied from rapid biphasic ones (Figs. 1, 2A, and 3A) to slower monophasic ones (Fig. 2B). The kinetics of the rapid component were independent of voltage. Once the contraction was initiated a rapid shortening and relengthening of the fast component occurred. We concluded this to be a SR-mediated event because this component was blocked by the SERCA inhibitor thapsigargin (Fig. 3).
As the pulse duration became very short in voltage-clamp experiments (i.e., 150-450 ms), the repolarization decreased the magnitude of the contraction, suggesting that the exchanger was able to rapidly remove intracellular calcium, effectively competing with the SR for calcium and abbreviating the contraction. This reduced magnitude of contraction due to shortening of the test pulse may partially explain the negative force-frequency relationship observed in failed human myocytes attributable to smaller calcium transients (9, 20). Sipido et al. (25) observed smaller calcium transients at higher stimulation frequencies in failed human myocytes and suggested that this was the basis for the negative force-frequency relationship. A similar phenomenon was observed in rat myocytes when rapid repolarization interrupted the rising phase and abbreviated the intracellular calcium transient (7). The sodium/calcium exchanger has been shown to compete with the SR for removal of intracellular calcium during very brief depolarizations (4). The rate of shortening of the second component was slower and clearly demonstrated a process of initiation of contraction separate from the SR. Our results suggest that reverse-mode sodium/calcium exchange was the source of activator calcium for direct activation of the myofilaments producing the second slow component.
The appearance of biphasic contractions in response to action potentials varied from cell to cell. We believe that the relative amount of SR dysfunction dictated this result. Approximately one-half of the myocytes we studied had single-phase contractions, the rate of shortening and relengthening of which was less. It appeared that these myocytes had severely limited SR function and depended to a greater extent on sodium/calcium exchange as a source of activator calcium. It was always possible to elicit some element of a biphasic response using a long voltage-clamp step (1,500 ms), suggesting that the SR plays at least some role in contraction even in severely diseased cells.
Complete relaxation of failed myocytes was closely linked to the repolarization at the end of the action potential or voltage-clamp test pulse. The kinetics of relaxation of the rapid (SR) component of contraction were independent of voltage and matched the rate of shortening of the rapid component. The kinetics of the slow component were strongly voltage dependent and always depended on the repolarization at the end of the action potential or voltage-clamp test pulse. Because the action potential duration is prolonged in human heart failure, the linking of relaxation to the action potential may contribute to the slower relaxation seen in failed human myocytes.
The identity of the two components of contractions has been addressed by Isenberg et al. (14). In guinea pig and bovine isolated myocytes, the rapid component was independent of voltage, and they concluded that the rapid component depended on intracellular calcium stores (SR).
In our experiments, further evidence about the identity of the two components of contraction was provided by repeating our experiments at 25°C. Because the sodium/calcium exchanger is highly temperature sensitive (21, 27), the effect of the exchanger on relaxation could be reduced by recording action potentials and contractions at 25°C. Although the duration of the action potentials and contractions were longer at 25°C, the relaxation phase was no longer linked to the repolarization of the action potential. Likewise, when voltage-clamp experiments were carried out at 25°C, relaxation was no longer dependent on the repolarization and changing pulse duration. We believe by using this method of reducing exchanger activity we were able to visualize the contribution of the exchanger to relaxation.
We further explored the role of the exchanger in contraction and relaxation of failed myocytes using KB-7943, a specific blocker of sodium/calcium exchange (15). KB-7943 caused significant shortening of the action potential, suggesting that the sodium/calcium exchange current is a significant contributor to the action potential plateau as suggested by Schouten et al. (24). Contractions resulting from shortened action potentials and from voltage-clamp steps in the presence of KB-7943 were small and independent of repolarization. In the voltage-clamp experiments, the characteristic exchange current was blocked by KB-7943, leaving only L-type calcium current as a source of activator calcium. The meager contractions in the absence of sodium/calcium exchange are strong evidence of the importance of the exchanger in the initiation of contraction and SR loading in failed myocytes. The slow rate of relaxation in the presence of KB-7943 provides further evidence of the prominent role of the exchanger in relaxation.
Thapsigargin has been successfully used as a selective blocker of SERCA in cardiac myocytes (16). By exposing myocytes to thapsigargin, we were able to virtually eliminate SR function. Thapsigargin had no effect on the action potential waveshape but dramatically slowed the rate of contraction similar to the result reported by Davia et al. (8). In voltage-clamp experiments when L-type calcium current was the primary source of activator calcium, the contractions were very small and likely resulted from direct activation of the myofibrils. When the voltage-clamp step activated reverse-mode sodium/calcium exchange, the resulting contraction was much larger but still slow, consistent with direct activation of the myofibrils. Without a functional SR, reverse-mode exchange contributes to the direct activation of the contractile machinery at physiological overshoot voltages (+50 mV, Fig. 4B) more effectively than L-type calcium current (+10 mV, Fig. 4C). With the SR incapacitated, the sodium/calcium exchanger was left as the principal mechanism of relaxation and was closely linked to repolarization. Voltage-dependent relaxation was apparent regardless of the stimulus for the contraction. These data strongly support the hypothesis that the exchanger is a primary mechanism of relaxation in failed human myocytes.
Further evidence supporting the key role of sodium/calcium exchange in contraction and relaxation comes from experiments showing the capability of the exchange-mediated calcium influx to progressively increase the size of contraction with repetitive voltage-clamp steps (Fig. 5, B and C). This result shows indirectly that reverse-mode exchange can load the SR and initiate contraction. Consistent with other experiments, relaxation of these contractions was voltage dependent, indicating reliance on the exchanger for relaxation.
The results of the present investigation suggest that the upregulation of the exchanger in human heart failure (1, 18, 26) provides an extra source of activator calcium via reverse-mode exchange for activation of the myofibrils in the face of severe SR dysfunction and also functions as a major process of relaxation via forward-mode exchange. Because the SR is reported to be downregulated in heart failure (1, 12, 13, 18, 19, 26), we believe the upregulation of the exchanger may be an adaptation for SR loss.
The limitations of our study surround the difficulty in obtaining normal human tissue for comparison. Similar studies on normal human myocytes are needed before firm conclusions about human heart failure can be made. There was a large degree of heterogeneity among the different etiologies of heart failure and even among individual myocytes from a single preparation. The heterogeneity may reflect the chronic and complex nature of end-stage human heart failure. No difference between failed hearts of different etiologies could be discerned.
In summary, we conclude that the sodium/calcium exchanger plays a key role in both contraction and relaxation of failed human myocytes. Our data suggest that in human heart failure there are varying degrees of contractile dysfunction that reflect the decreased level of SERCA. The increased exchanger activity may be an adaptation for this dysfunction, providing an alternative and/or complementary mechanism of contraction and relaxation.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: J. P. Gaughan, Dept. of Physiology, Temple University School of Medicine, 3420 North Broad Street, Philadelphia, PA 19140 (E-mail: jgaughan<debjohn{at}pond.com>).
Received 29 December 1998; accepted in final form 17 March 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arai, M.,
N. R. Alpert,
D. H. MacLennan,
P. Barton,
and
M. Periasamy.
Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.
Circ. Res.
72:
463-469,
1993
2.
Barry, W. H.,
C. A. F. Rasmussen,
H. Ishida,
and
J. H. B. Bridge.
External Na-independent Ca extrusion in cultured ventricular cells.
J. Gen. Physiol.
88:
393-411,
1986
3.
Bassani, R. A.,
J. W. M. Bassani,
and
D. M. Bers.
Mitochondrial and sarcolemmal Ca2+ transport reduce [Ca2+]i during caffeine contractures in rabbit cardiac myocytes.
J. Physiol. (Lond.)
453:
591-608,
1992
4.
Bers, D. M.,
W. J. Lederer,
and
J. R. Berlin.
Intracellular Ca transients in rat cardiac myocytes: role of Na-Ca exchange in excitation-contraction coupling.
Am. J. Physiol.
258 (Cell Physiol. 27):
C944-C954,
1990
5.
Beukelmann, D. J.,
M. Nabauer,
and
E. Erdmann.
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.
Circulation
85:
1046-1055,
1992
6.
Beukelmann, D. J.,
M. Nabauer,
and
E. Erdmann.
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure.
Circ. Res.
73:
379-385,
1993
7.
Cannell, M. B.,
J. R. Berlin,
and
W. J. Lederer.
Effect of membrane potential changes on the calcium transient in single rat cardiac muscle cells.
Science
238:
1419-1423,
1987
8.
Davia, K.,
C. H. Davies,
and
S. E. Harding.
Effects of inhibition of sarcoplasmic reticulum calcium uptake on contraction in myocytes isolated from failing human ventricle.
Cardiovasc. Res.
33:
88-97,
1997
9.
Davies, C. H.,
K. Davia,
J. G. Bennett,
J. R. Pepper,
P. A Poole-Wilson,
and
S. E. Harding.
Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure.
Circulation
92:
2540-2549,
1995
10.
Finkel, A. S.,
and
S. J. Redman.
Theory and operation of a single microelectrode voltage clamp.
J. Neurosci. Methods
11:
101-127,
1984[Medline].
11.
Gwathmey, J. K.,
L. Copelas,
R. MacKinnon,
F. J. Schoen,
M. D. Feldman,
W. Grossman,
and
J. P. Morgan.
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Circ. Res.
61:
70-76,
1987
12.
Hasenfuss, G.
Alterations of calcium-regulatory proteins in heart failure.
Cardiovasc. Res.
37:
279-289,
1988.
13.
Hasenfuss, G.,
H. Reinecke,
R. Studer,
M. Meyer,
B. Pieske,
J. Holtz,
C. Holubarsch,
H. Posival,
H. Just,
and
H. Drexler.
Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+ ATPase in failing and nonfailing human myocardium.
Circ. Res.
75:
434-442,
1994
14.
Isenberg, I.,
A. Beresewicz,
D. Mascher,
and
F. Valenzuela.
The two components in the shortening of unloaded ventricular myocytes: their voltage dependence.
Basic Res. Cardiol.
80, Suppl. 1:
117-121,
1985.
15.
Iwamoto, T.,
T. Watano,
and
M. Shigekawa.
A novel isothiourea derivative selectively inhibits the reverse mode of Na+/ Ca2+ exchange in cells expressing NCX1.
J. Biol. Chem.
271:
22391-22397,
1996
16.
Kirby, M. S.,
Y. Sagara,
S. Gaa,
G. Inesi,
W. J. Lederer,
and
T. B. Rogers.
Thapsigargin inhibits contraction, and Ca2+ transient in cardiac cells by specific inhibition of the sarcoplasmic reticulum Ca2+ pump
J. Biol. Chem.
267:
12545-12551,
1992
17.
Lindner, M.,
E. Erdmann,
and
D. J. Beukelmann.
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure.
J. Mol. Cell. Cardiol.
30:
743-749,
1998[Medline].
18.
Link, B.,
P. Boknick,
T. Eschenhagen,
F. U. Miller,
J. Neumann,
M. Nose,
L. R. Jones,
W. Schmitz,
and
H. Scholz.
Messenger RNA expression and immunological quantification of phospholamban and SR Ca-ATPase in failing and nonfailing human hearts.
Cardiovasc. Res.
31:
625-632,
1996[Medline].
19.
Mercadier, J. J.,
A. M. Lompre,
P. Duc,
K. R. Boheler,
J. B. Fraysse,
C. Wisnewsky,
P. D. Allen,
M. Komajda,
and
K. Schwartz.
Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure.
J. Clin. Invest.
85:
305-309,
1990.
20.
Mulieri, L. A.,
G. Hasenfuss,
B. Leavitt,
P. D. Allen,
and
N. R. Alpert.
Altered myocaridal force-frequency relation in human heart failure.
Circulation
85:
1743-2750,
1992
21.
Puglisi, J. L.,
R. A. Bassani,
J. W. M. Bassani,
and
D. M. Bers.
Temperature and relative contributions of Ca transport systems in cardiac myocyte relaxation.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1772-H1778,
1996
22.
Schlotthauer, K.,
J. Schattmann,
D. M. Bers,
L. S. Maier,
U. Schutt,
K. Minami,
H. Just,
G. Hasenfuss,
and
B. Pieske.
Frequency-dependent changes in contribution of SR Ca2+ to Ca2+ transients in failing human myocardium assessed with ryanodine.
J. Mol. Cell. Cardiol.
30:
1285-1294,
1998[Medline].
23.
Schmidt, U.,
R. J. Hajjir,
P. A. Helm,
C. S. Kim,
A. A. Doye,
and
J. K. Gwathmey.
Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure.
J. Mol. Cell. Cardiol.
30:
1929-1937,
1998[Medline].
24.
Schouten, V. J. A.,
H. E. D. J. ter Keurs,
and
J. M. Quaegebeur.
Influence of Na/Ca exchange on the action potential in human heart muscle.
Cardiovasc. Res.
24:
758-768,
1990[Medline].
25.
Sipido, K. R.,
T. Stankovicova,
W. Flameng,
J. Vanhaeke,
and
F. Verdonck.
Frequency dependence of Ca2+ release from the sarcoplasmic reticulum in human ventricular myocytes from end-stage heart failure.
Cardiovasc. Res.
37:
478-488,
1998
26.
Studer, R.,
H. Reinecke,
H., J. Bilger,
T. Eschenhagen,
M. Bohm,
G. Hassenfuss,
H. Just,
J. Holtz,
and
H. Drexler.
Gene expression of the cardiac Na-Ca exchanger in end-stage human heart failure.
Circ. Res.
75:
443-453,
1994
27.
Vornanen, M.,
N. Shepherd,
and
G. Isenberg.
Tension-voltage relations of single myocytes reflect Ca release triggered by exchange at 35°C but not 23°C.
Am. J. Physiol.
267 (Cell Physiol. 36):
C623-C632,
1994
28.
Wigle, E. D. The failing heart. In:
Diastolic Dysfunction: Pathophysiology and Treatment
Options. Philadelphia, PA: Lippincott-Raven, chapt. 7, p.79-94, 1995.
29.
Wolff, M. R.,
S. H. Buck,
S. W. Stoker,
M. L. Greaser,
and
R. M. Mentzer.
Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered
-adrenergically mediated protein phosphorylation.
J. Clin. Invest.
98:
167-176,
1996[Medline].
30.
Yao, A.,
H. Matsui,
K. W. Spitzer,
J. H. B. Bridge,
and
W. H. Barry.
Sarcoplasmic reticulum and Na/Ca exchanger function during early and late relaxation in ventricular myocytes.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H2765-H2773,
1997
This article has been cited by other articles:
![]() |
J. A. Wasserstrom and G. L. Aistrup Digitalis: new actions for an old drug Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1781 - H1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, X.-Q. Zhang, J. Wang, L. L. Carl, B. A. Ahlers, L. I. Rothblum, and J. Y. Cheung Sprint training improves contractility in postinfarction rat myocytes: role of Na+/Ca2+ exchange J Appl Physiol, August 1, 2004; 97(2): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. De Jongh, V. Ramanathan, B. K. Hoffmeister, and R. A. Malkin Left ventricular geometry immediately following defibrillation: shock-induced relaxation Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H815 - H819. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhang, J. Song, A. Qureshi, L. I. Rothblum, L. L. Carl, Q. Tian, and J. Y. Cheung Rescue of contractile abnormalities by Na+/Ca2+ exchanger overexpression in postinfarction rat myocytes J Appl Physiol, December 1, 2002; 93(6): 1925 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shenoy, I. Klein, and K. Ojamaa Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1690 - H1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Elias, A. Lukas, S. Shurraw, J. Scott, A. Omelchenko, G. J. Gross, M. Hnatowich, and L. V. Hryshko Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1334 - H1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Barry Na+-Ca2+ Exchange in Failing Myocardium : Friend or Foe? Circ. Res., September 29, 2000; 87(7): 529 - 531. [Full Text] [PDF] |
||||
![]() |
L.-Q. Zhang, X.-Q. Zhang, T. I. Musch, R. L. Moore, and J. Y. Cheung Sprint training restores normal contractility in postinfarction rat myocytes J Appl Physiol, September 1, 2000; 89(3): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bers Calcium Fluxes Involved in Control of Cardiac Myocyte Contraction Circ. Res., August 18, 2000; 87(4): 275 - 281. [Full Text] [PDF] |
||||
![]() |
J. A. Wasserstrom, E. Holt, I. Sjaastad, P. K. Lunde, A. Odegaard, and O. M. Sejersted Altered E-C coupling in rat ventricular myocytes from failing hearts 6 wk after MI Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H798 - H807. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Q. Zhang, X.-Q. Zhang, Y.-C. Ng, L. I. Rothblum, T. I. Musch, R. L. Moore, and J. Y. Cheung Sprint training normalizes Ca2+ transients and SR function in postinfarction rat myocytes J Appl Physiol, July 1, 2000; 89(1): 38 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, B. Nolan, W. Kutschke, and J. A. Hill Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac Hypertrophy J. Biol. Chem., May 18, 2001; 276(21): 17706 - 17711. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |